A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

CITREPORE is an exciting addition to Acuitive's product portfolio and provides a unique opportunity for its use in numerous ...

Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a unique synthetic bioactive bone void filler, using ...

A veteran’s life has been forever changed after a selfless act for his community. Someone who saw his story wanted to do ...

According to Miach Orthopaedics, “The BEAR Implant is the first disruptive technology in ACL [anterior cruciate ligament] ...

Simultaneously, the patient becomes aware of a salty taste because the intralobular ducts have not adequately resorbed sodium and chloride ions from the saliva. Furthermore, because salivary ...